The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Real-world study of imatinib treatment patterns and outcomes among veteran patients with chronic myeloid leukemia.
Lizheng Shi
Research Funding - Novartis
Lei Chen
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Hari Sharma
Employment or Leadership Position - Analysis Group
Consultant or Advisory Role - Novartis
Maryna Marynchenko
Employment or Leadership Position - Analysis Group
Consultant or Advisory Role - Novartis
Eric Q. Wu
Employment or Leadership Position - Analysis Group
Consultant or Advisory Role - Novartis
Jinan Liu
No relevant relationships to disclose
Heidi Yang
No relevant relationships to disclose
Min Amy Guo
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Nancy S. Vander Velde
No relevant relationships to disclose